Irina Babina

Irina Babina has an extensive work experience in various fields. Irina is currently the Chief Business Officer at Concr since May 2023. Prior to this role, they served as the Head of Strategy at Concr from September 2022 to May 2023. Irina Babina also worked as a Venture Partner (Life Sciences) at Verve Ventures VC from April 2019 onwards. Irina worked as a Life Sciences Innovation and Strategy Consultant at B Co since April 2021.

In addition, Irina Babina has experience working at Imperial College Healthcare NHS Trust, where they served as a Commercial & Innovation Partner from November 2021 to March 2022. Irina also worked at Imperial College London, first as a Senior Research Programmes Manager from June 2021 to March 2022, and then as a Research Programmes Manager from July 2017 to June 2021.

Prior to these roles, Irina Babina worked as a Clinical Contractor at Antidote.me from February 2017 to February 2018. Irina also worked as a Postdoctoral Researcher at The Institute of Cancer Research from October 2013 to July 2017.

Earlier in their career, Irina Babina worked at Pfizer as part of the Drug Substance R&D team from March 2008 to September 2008. Irina also served as a Digital Pathology Consultant / Data Manager at Leica Microsystems (ePathology, SlidePath) from June 2007 to January 2008.

Irina Babina pursued their education chronologically, beginning in 2005 at Dublin City University. However, the specific degree and field of study they pursued during this time are not provided. In 2009, they graduated from the Royal College of Surgeons in Ireland (RCSI) with a PhD in the field of Triple-negative breast cancer metastasis.

Later, in 2017, Irina attended UCL and obtained a degree in Leadership in Action, focusing on Organizational Leadership. Lastly, from 2019 to 2021, they attended the Imperial College Business School, where they earned a Master of Business Administration (MBA). No additional information is provided regarding the field of study for their MBA.